Managed Access Programs for PKC412, Midostaurin
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
- Status
- RECRUITING
- Phase
- N/A
Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP
- Status
- COMPLETED
- Phase
- N/A
Study to Demonstrate the Efficacy and Safety of Secukinumab up to 224 Weeks in Subjects With Active Peripheral Spondyloarthritis (pSpA).
- Status
- WITHDRAWN
- Phase
- PHASE3
Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)
- Status
- TERMINATED
- Phase
- PHASE1
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM
- Status
- TERMINATED
- Phase
- PHASE2
Investigate Bioequivalence of Alpelisib Granule and Film-coated Tablet Formulation and the Food Effect of Alpelisib Granule Formulation in Adult Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE4
A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data
- Status
- COMPLETED
- Phase
- N/A
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
- Status
- COMPLETED
- Phase
- N/A
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
- Status
- TERMINATED
- Phase
- PHASE3
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
- Status
- TERMINATED
- Phase
- PHASE3
Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria
- Status
- AVAILABLE
- Phase
- N/A
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Immune Profiles in Multiple Sclerosis (MS) Patients and Healthy Volunteers Through Thoracic Duct Cannulation
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Roll-over Study to Allow Continued Access to Ribociclib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4